DWM
AVNS

Destination Wealth Management’s Avanos Medical AVNS Stock Holding History

Destination Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-37
Closed -$2K – 689
2018
Q2 		$2K Buy
+37
New +$1.96K ﹤0.01% 468

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Destination Wealth Management's AVNS Position: Q3 2018 in Review

Destination Wealth Management sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 37 shares — an estimated $2K sold.

Destination Wealth Management first reported a position in AVNS in Q2 2018 and held it in 1 quarter. The position peaked at $2K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

  • Destination Wealth Management reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
  • Destination Wealth Management sold 37 Avanos Medical shares in Q3 2018, an estimated $2K.
  • Destination Wealth Management first reported a position in Avanos Medical in Q2 2018 and held it in 1 quarter.
  • Destination Wealth Management's Avanos Medical position peaked at $2K in Q2 2018.
  • 387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Destination Wealth Management's 13F filing for Q3 2018, filed 7 Nov 2018.